SAN FRANCISCO — Patients who use GLP-1 receptor agonists (GLP-1 RAs) both before and after undergoing bariatric surgery experience greater weight loss than with surgery alone, new data suggested. The ...

Reductions in measured GFR after bariatric surgery were positively correlated with baseline measured GFR before surgery, ...

In a retrospective study, semaglutide use leading up to bariatric surgery was not linked with greater weight loss a year after surgery. Rates of diabetes remission and complications were also ...

Among patients with obesity and type 2 diabetes (T2D), those who underwent metabolic bariatric surgery experienced greater weight loss and reductions in A1c levels than patients who did not undergo ...

GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found. Patients ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, ...

Some people don’t lose enough weight after bariatric surgery, but a new study shows that adding a daily shot of GLP-1 drug liraglutide can help patients shed extra pounds and may reduce the need for ...

A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated ...

The center incorporates the hospital's bariatric surgery program.

While these drugs can help patients shed pounds, they are not a permanent solution. Most people regain nearly 70% of lost weight within a year of stopping treatment, and long-term effects remain ...